Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01XEO
|
||||
Former ID |
DIB007323
|
||||
Drug Name |
Debio-0824
|
||||
Synonyms |
Debio-0824; ShK-186; Shk-192; ShK analogs (Subcutaneous formulation, autoimmune disease), Kineta; Stichodactyla helianthus-derived Kv1.3 potassium channel inhibitors (injectable peptide, autoimmune disease); Stichodactyla helianthus-derived Kv1.3 potassium channel inhibitor (Subcutaneous formulation, autoimmune disease), Airmid; Stichodactyla helianthus-derived Kv1.3 potassium channel inhibitor (injectable peptide, autoimmune disease), Davis; Stichodactyla helianthus-derived Kv1.3 potassium channel inhibitors (injectable peptide, autoimmune disease), Kineta One
|
||||
Indication | Psoriatic arthritis [ICD9: 696; ICD10:L40.5, M07] | Phase 1 | [525193] | ||
Company |
Kineta
|
||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily A member 3 | Target Info | Inhibitor | [544248] | |
Reactome | Voltage gated Potassium channels | ||||
WikiPathways | Potassium Channels | ||||
BDNF signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.